MONTECALVO DAVID A 4

Accession 0001562180-20-005231

CIK 0000105770other

View on SEC.gov Company Profile

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 6:22 PM ET

Size

25.2 KB

Accession

0001562180-20-005231

Insider Transaction Report

Form 4

Period: 2020-07-28

WEST PHARMACEUTICAL SERVICES INCWST

MONTECALVO DAVID A

SVP, Glob Ops and Supply Chain

Transactions

Sale
Common Stock
2020-07-28$264.13/sh−7,773$2,053,094→ 10,243.42 total
Exercise/Conversion
Common Stock
2020-07-29$83.47/sh+5,358$447,232→ 9,582.42 total
Exercise/Conversion
Common Stock
2020-07-28$83.47/sh+3,000$250,410→ 18,732.42 total
Sale
Common Stock
2020-07-28$265.98/sh−3,000$797,931→ 4,224.42 total
Sale
Common Stock
2020-07-28$265.13/sh−2,881$763,837→ 7,362.42 total
Exercise/Conversion
Stock Options (Right to buy)
2020-07-29−5,358→ 2,786 total
Exercise: $83.47From: 2018-02-21Exp: 2027-02-21→ Common Stock (5,358 underlying)
Exercise/Conversion
Common Stock
2020-07-28$71.79/sh+10,792$774,758→ 15,732.42 total
Sale
Common Stock
2020-07-28$266.06/sh−716$190,498→ 18,016.42 total
Sale
Common Stock
2020-07-28$265.85/sh−138$36,687→ 7,224.42 total
Sale
Common Stock
2020-07-29$270.70/sh−3,273$886,014→ 6,309.42 total
Exercise/Conversion
Stock Option (Right to Buy)
2020-07-28−10,792→ 0 total
Exercise: $71.79From: 2017-02-23Exp: 2026-09-26→ Common Stock (10,792 underlying)
Exercise/Conversion
Stock Options (Right to buy)
2020-07-28−3,000→ 8,144 total
Exercise: $83.47From: 2018-02-21Exp: 2027-02-21→ Common Stock (3,000 underlying)

Footnotes (4)

[F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $263.80 to $264.79, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
[F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $264.80 to $265.77, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
[F3]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.80 to $265.87, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
[F4]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.9762 to $265.9769, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

→

Entity typeother

Related Parties

filerCIK 0001241973

Filing Metadata

Form type: 4
Filed: Jul 29, 8:00 PM ET
Accepted: Jul 30, 6:22 PM ET
Size: 25.2 KB

View on SEC.gov